Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 101 of 144 pages ‹ First < 99 100 101 102 103 > Last ›
HSL4608
Lurie P
Testimony before the Senate Special Committee on Aging on The Impact of Direct-to-Consumer Drug Advertising on Seniors’ Health and Health Care Costs (HRG Publication #1751)
: Health Research Group 2005 Sep 29
http://www.citizen.org/publications/release.cfm?ID=7402
HSL2563
My e Portal
Pfizer 2005 Sep 28
http://www.myeportal.com.au/Public/DoctorPortal/Default.aspx
HSL2595
Labeling Change Request Letter for Antidepressant Medications
FDA 2005 Sep 28
http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm096352.htm
HSL2596
Boseley S.
GPs to stop prescribing antidepressants blamed for suicidal feelings in under-18s
The Guardian ( UK) 2005 Sep 28
http://www.guardian.co.uk/uk_news/story/0,3604,1579775,00.html
HSL2608
Heller L.
UK to announce school junk food ban
Nutra Ingredients.com 2005 Sep 28
http://www.nutraingredients.com/news/ng.asp?n=62839&m=1nie928&c=cvanbcdtfnlfwtl
HSL2636
Female and Elder Consumers and Payers Sue Pfizer Over Deceptive Marketing of Lipitor®
Hagens Berman Sobol Shapiro LLP 2005 Sep 28
http://www.hbsslaw.com/press_release_Lipitor.htm
HSL2598
Reuters .
Glaxo adds birth defect caution to Paxil label
Yahoo News ( via Reuters) 2005 Sep 27
http://news.yahoo.com/s/nm/20050927/hl_nm/glaxosmithkline_paxil_dc
HSL2600
Saul S, Pear R.
F.D.A. Chief Quit Over Financial Disclosure Form, His Wife's Brother Says
New York Times 2005 Sep 27
http://www.nytimes.com/2005/09/28/politics/28fda.html?pagewanted=print
HSL2601
Boseley S.
Authorities accused of failing to tackle causes of breast cancer
The Guardian ( UK) 2005 Sep 27
http://www.guardian.co.uk/uk_news/story/0,3604,1579636,00.html
HSL2621
Lenzer J.
What the FDA isn't telling.
Slate 2005 Sep 27
http://slate.msn.com/id/2126918/
HSL4773
Nissen SE; Cardiovascular and Renal Drugs Advisory Committee.
Report from the Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration; June 15-16, 2005; Gaithersburg, Md.
Circulation 2005 Sep 27; 112:(13):2043-6
http://circ.ahajournals.org/cgi/content/full/113/10/e394
HSL2637
Park J, White AR, James MA, Hemsley AG, Johnson P, Chambers J, Ernst E.
Acupuncture for subacute stroke rehabilitation: a Sham-controlled, subject- and assessor-blind, randomized trial.
Arch Intern Med 2005 Sep 26; 165:(17):2026-31
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16186474&query_hl=1
HSL2597
Eberstadt M.
A prescribed threat
Los Angeles Times 2005 Sep 25
http://www.latimes.com/news/opinion/commentary/la-oe-eberstadt25sep25,0,3602544.story?coll=la-news-comment-opinions
HSL19785
Smith P
CPD debate: Call to limit sponsorship slated
Australian Doctor 2005 Sep 25
http://www.australiandoctor.com.au/news/cpd-debate--call-to-limit-sponsorship-slated
HSL2533
Alonso-zaldivar R.
FDA Chief Crawford Resigns 2 Months After Confirmation
Los Angeles Times 2005 Sep 24
http://www.latimes.com/news/printedition/asection/la-na-fda24sep24,1,1152320.story?page=2
HSL2534
Pear R, Pollack A.
Leader of the F.D.A. Steps Down After a Short, Turbulent Tenure
New York Times 2005 Sep 24
http://query.nytimes.com/search/query?ppds=bylL&v1=ROBERT%20PEAR&fdq=19960101&td=sysdate&sort=newest&ac=ROBERT%20PEAR&inline=nyt-per
HSL2535
Neergaard L.
FDA Commissioner Lester Crawford Resigns
SFGate ( via AP) 2005 Sep 24
http://sfgate.com/cgi-bin/article.cgi?file=/news/archive/2005/09/23/national/w130151D52.DTL
HSL2536
Lenzer J.
Doctors refuse space to group fighting drug company influence
BMJ 2005 Sep 24
http://bmj.bmjjournals.com/cgi/content/full/331/7518/653-a?ehom
HSL19774
Limprecht E
Pfizer web site tracks GP use
Australian Doctor 2005 Sep 23
http://www.australiandoctor.com.au/news/pfizer-web-site-tracks-gp-use
HSL2524
Lieberman J.
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
New England Journal of Medicine 2005 Sep 22; 353:(no. 12):
http://content.nejm.org/cgi/reprint/NEJMoa051688.pdf
HSL2523
Ford A.
Financial conflict of interest for members on breast implant advisory panel unacceptable
Women and Health Protection ( Canada) 2005 Sep 21
http://www.whp-apsf.ca
HSL2525
Vedantam S.
New Antipsychotic Drugs Criticized
Washington Post 2005 Sep 20
http://www.washingtonpost.com/wp-dyn/content/article/2005/09/19/AR2005091901867_pf.html
HSL2526
Aboud L.
The Wall Street Journal, Generic Fares Well in Big Psychiatry Study
The Wall Street Journal 2005 Sep 20
http://online.wsj.com/public/us?mod=network_opinionjournal
HSL2527
Cook L.
Meeting Women's Desire for Desire (Testosterone Fix Risky, Say Some Experts)
Washington Post 2005 Sep 20
http://www.washingtonpost.com/wp-dyn/content/article/2005/09/19/AR2005091901235.html
HSL2650
$95 billion a year spent on medical research- Report questions whether money is well spent on important diseases
Associated Press ( on MSNBC ) 2005 Sep 20
http://msnbc.msn.com/id/9407342/
HSL2710
Purves L.
Shut up and take your pills
Times Online 2005 Sep 20
http://www.timesonline.co.uk/article/0,,1056-1788223,00.html
HSL2519
Gottstein J.
Katrina Victims Need Homes, Money, Jobs and Support -- Not Psychiatric Drugs
PsychRights 2005 Sep 19
http://psychrights.org/
HSL2522
Disease Mongering
The Breast Views (blogspot) 2005 Sep 19
http://thebreastviews.blogspot.com/2005/09/breast-views-blog-disease-mongering.html
HSL2537
Donnell R.
No Free Lunch may be striking a nerve with professional societies
Dr R W Donnell's Blogspot 2005 Sep 19
http://doctorrw.blogspot.com/2005/09/no-free-lunch-may-be-striking-nerve_19.html
HSL2624
Bockmann M.
Generation Ritalin
The Australian Newspaper 2005 Sep 19
http://www.theaustralian.news.com.au/common/story_page/0,5744,16644615%5E28737,00.html
HSL2516
Nikkhah R.
Alarm as prescriptions of Ritalin to children reach a record high
The Daily Telegraph (UK) 2005 Sep 18
http://www.telegraph.co.uk/news/main.jhtml?xml=/news/2005/09/18/nrit18.xml
HSL2520
Poses R.
AAFP: No Entry to No Free Lunch
Health Care Renewal ( blogspot ) 2005 Sep 17
http://hcrenewal.blogspot.com/2005/09/aafp-no-entry-to-no-free-lunch.html
HSL2514
Edwards J.
“No Free Lunch” Gets No Free Ride
Brandweek 2005 Sep 16
http://www.brandweek.com/bw/news/recent_display.jsp?vnu_content_id=1001138393
HSL5467
Mansfield PR.
Response to Jeffrey Mann: Clinical trials never produce certainty
BMJ 2005 Sep 16; 331:
http://bmj.bmjjournals.com/cgi/eletters/331/7516/528
HSL2515
Quit looking for a miracle cure
The Telegram (St John's Newfoundland Canada) 2005 Sep 15
http://thetelegram.com/news.aspx?pname=Lifestyles§ion=Lifestyles
HSL20074
Fleming K
Changes ordered to 40 software ads to comply with code
Medical Observer 2005 Sep 152
HSL2434
Marketing & Support Opportunities, American Academy of Family Physicians , Scientific Assembly 2005
American Academy of Family Physicians 2005 Sep 14
http://www.aafp.org/PreBuilt/assembly_exhibits_adopps.pdf
HSL2443
Coping with coming off exposes serious difficulties in doctor-patient relationship
Mind (' for better mental health', UK) 2005 Sep 14
http://www.mind.org.uk/News%2Bpolicy%2Band%2Bcampaigns/Press/CWCO0905.htm
HSL4436
Kron J.
To see or not to see.
Australian Doctor Weekly 2005 Sep 14
HSL4568
Waeber B, Burnier M, Pechere-Bertschi A.
[Drug industry influence on hypertension treatment trials].
Rev Med Suisse 2005 Sep 14; 1:(32):2067-8
HSL2435
Otto A.
Are ADHD drugs safe? Report finds little proof
The News Tribune ( Tacoma ) 2005 Sep 13
http://www.thenewstribune.com/news/local/story/5174797p-4705010c.html
HSL2444
Regulating a Faulty Heart Device
New York Times 2005 Sep 13
http://www.nytimes.com/glogin?URI=http://www.nytimes.com/2005/09/13/opinion/13tue2.html&OQ=nQ3DTopQ252FOpinionQ252FEditorialsQ2520andQ2520Op-EdQ252FEditorials&OP=2af836d3Q2FQ255ulQ25gjUTQ5Djj8Q7CQ25Q7Ccc)Q25c2Q25Q3EQ2AQ25jQ5EQ7BQ3FQ7BjQ3FQ25Q3EQ2A8,uQ7CqQ518GY
HSL2517
Cresswell A.
GP education filled with 'propaganda'
The Australian Newspaper 2005 Sep 13
http://www.theaustralian.news.com.au/common/story_page/0,5744,16583953%255E23289,00.html
HSL2518
Drug companies deny profit accusations
The Age (Melbourne) 2005 Sep 13
http://www.theage.com.au/news/National/Drug-companies-deny-profit-accusations/2005/09/13/1126377301287.html
HSL5468
Mansfield PR.
Celecoxib causes excess cardiovascular events and illustrates the folly of allowing drug sellers too much power.
BMJ 2005 Sep 10; 331:
http://bmj.bmjjournals.com/cgi/eletters/331/7516/528
HSL2427
FDA Lets Scientists With Drug Company Ties Evaluate New Insulin Product
Center for Science in the Public Interest 2005 Sep 9
http://www.cspinet.org/new/200509091.html
HSL2429
Xinhua .
China, US jointly seize 440,000 pills of counterfeit Viagra
People's Daily Online ( China ) 2005 Sep 9
http://english.people.com.cn/200509/09/eng20050909_207454.html
HSL2430
Toland B.
Against odds, Kevin Trudeau still king of late-night infomercial pitchmen
Post-Gazette.com 2005 Sep 9
http://www.post-gazette.com/pg/05252/568248.stm
HSL2431
Picard A.
'New' drugs too often offer little new
The Globe and Mail ( Canada) 2005 Sep 8
http://www.theglobeandmail.com/servlet/ArticleNews/TPStory/LAC/20050908/HPICARD08/TPNational/Canada
HSL2432
Avorn J.
FDA Standards — Good Enough for Government Work?
New England Journal of Medicine 2005 Sep 8
http://content.nejm.org/cgi/content/full/353/10/969?query=TOC
HSL2425
Sierles FS, Brodkey AC, Cleary LM, McCurdy FA, Mintz M, Frank J, Lynn DJ, Chao J, Morgenstern BZ, Shore W, Woodard JL
Medical Students’ Exposure to and Attitudes About Drug Company Interactions
JAMA 2005 Sep 7; 295:(3):281-282
doi: 10.1001/jama.295.3.281-b
http://jama.ama-assn.org/cgi/content/abstract/294/9/1034
HSL5295
Fordis M, King JE, Ballantyne CM, Jones PH, Schneider KH, Spann SJ, Greenberg SB, Greisinger AJ.
Comparison of the instructional efficacy of Internet-based CME with live interactive CME workshops: a randomized controlled trial.
JAMA 2005 Sep 7; 294:(9):1043-51
http://jama.ama-assn.org/cgi/content/full/294/9/1043
HSL19508
Sierles FS, Brodkey AC, Cleary LM, McCurdy FA, Mintz M, Frank J, Lynn DJ, Chao J, Morgenstern BZ, Shore W, Woodard JL.
Medical students' exposure to and attitudes about drug company interactions: a national survey.
JAMA 2005 Sep 7; 294:(9):1034-42
http://www.ncbi.nlm.nih.gov/pubmed/16145023?dopt=Abstract
HSL2521
Angell M.
The Body Hunters ( a review of the book and film of 'The Constant Gardener' )
The New York Review of Books 2005 Sep 6
http://www.nybooks.com/articles/18301
HSL2422
Ross E.
Vitamin B Pills May Not Stop Heart Attacks
Seattle Post-Intelligencer ( via AP ) 2005 Sep 5
http://seattlepi.nwsource.com/national/apscience_story.asp?category=1500&slug=Vitamin%20B
HSL2420
Government Response to the Health Committee’s Report on the Influence of the Pharmaceutical Industry
British Government 2005 Sep 4
HSL2421
Hunter S.
The Zeal Thing
Washington Post 2005 Sep 4
http://www.washingtonpost.com/
HSL2437
Tanne JH.
Merck faces ongoing claims after Texan ruling on rofecoxib.
BMJ 2005 Sep 3; 331:(7515):471
http://bmj.bmjjournals.com/cgi/content/full/331/7515/471
HSL2438
Tanne JH.
US National Institutes of Health issue new ethics guidelines.
BMJ 2005 Sep 3; 331:(7515):472
http://bmj.bmjjournals.com/cgi/content/full/331/7515/472-b
HSL2439
Eaton L.
BMA warns against unnecessary screening tests in private sector.
BMJ 2005 Sep 3; 331:(7515):475
http://bmj.bmjjournals.com/cgi/content/full/331/7515/475-b
HSL2440
Kmietowicz Z.
Results of publicly funded research should be available to all, says web creator.
BMJ 2005 Sep 3; 331:(7515):476
http://bmj.bmjjournals.com/cgi/content/full/331/7515/476-c
HSL2441
Herbert RD, Bo K.
Analysis of quality of interventions in systematic reviews.
BMJ 2005 Sep 3; 331:(7515):507-9
http://bmj.bmjjournals.com/cgi/content/full/331/7515/507?etoc
HSL2407
Gerstel J.
Pushing Pills down our Throats
Toronto Star 2005 Sep 2
http://www.thestar.com/NASApp/cs/ContentServer?pagename=thestar/Render&inifile=futuretense.ini&c=Page&cid=991479973472&pubid=968163964505
HSL2445
Associated Press.
Lilly wants insurers to pay much of $1 billion in Zyprexa claims
Indianapolis Star ( via Associated Press) 2005 Sep 2
http://www2.indystar.com/articles/3/240135-7513-127.html
HSL2599
Rosack J.
New Data Show Declines In Antidepressant Prescribing
Psychiatric News ( psychiatry online) 2005 Sep 2
http://pn.psychiatryonline.org/cgi/content/short/40/17/1-a
HSL5290
Wall TC, Mian MA, Ray MN, Casebeer L, Collins BC, Kiefe CI, Weissman N, Allison JJ.
Improving physician performance through Internet-based interventions: who will participate?
J Med Internet Res 2005 Sep 2; 7:(4):e48
http://www.jmir.org/2005/4/e48/
HSL19843
Ferguson H
Divisions to expand drug savings program
Australian Doctor 2005 Sep 23
http://www.australiandoctor.com.au/news/divisions-to-expand-drug-savings-program
HSL20070
Limprecht E
Medical Director ads to be scrutinised
Australian Doctor 2005 Sep 212
HSL2416
Slattery-moschkau K.
Side Effects ( the movie )
Kathleen Slattery-Moschkau 2005 Sep 1
http://www.sideeffectsthemovie.com/home.shtml
HSL3738
Jayaraman KS.
Biotech boom.
Nat Biotechnol 2005 Sep 01; 23:(9):1183-4
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3094&uid=16151411&db=pubmed&url=http://dx.doi.org/10.1038/nbt0905-1183
HSL3759
Verdoux H, Cougnard A, Grolleau S, Begaud B.
Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care.
Schizophr Res 2005 Sep 1; 77:(1):107-9
http://linkinghub.elsevier.com/retrieve/pii/S0920-9964(05)00066-6
HSL4565
Preston P.
Persuasion: what to say, how to be.
J Healthc Manag 2005 Sep-Oct; 50:(5):294-6
HSL4579
Wager E.
Good practice for publishing the results of clinical trials.
J Br Menopause Soc 2005 Sep; 11:(3):109-11
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3152&uid=16157002&db=PubMed&url=http://openurl.ingenta.com/content/nlm?genre=article&issn=1362-1807&volume=11&issue=3&spage=109&aulast=Wager
HSL4583
Iijima H, Kamei M, Koshimizu T, Shiragami M.
[Evaluation of information for generic drugs based on importance and necessity].
Yakugaku Zasshi 2005 Sep; 125:(9):739-47
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3580&uid=16141694&db=PubMed&url=http://joi.jlc.jst.go.jp/JST.JSTAGE/yakushi/125.739?from=PubMed&lang=en
HSL4590
Banks D.
Pharmacists, pharmaceutical manufacturers, and conflicts of interest.
Am J Health Syst Pharm 2005 Sep 1; 62:(17):1827-32
http://www.ajhp.org/cgi/content/full/62/17/1827
HSL4757
Krieger N, Lowy I, Aronowitz R, Bigby J, Dickersin K, Garner E, Gaudilliere JP, Hinestrosa C, Hubbard R, Johnson PA, Missmer SA, Norsigian J, Pearson C, Rosenberg CE, Rosenberg L, Rosenkrantz BG, Seaman B, Sonnenschein C, Soto AM, Thornton J, Weisz G.
Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.
J Epidemiol Community Health 2005 Sep 01; 59:(9):740-8
http://jech.bmjjournals.com/cgi/content/full/59/9/740
HSL5048
Mastroianni Pde C, Galduroz JC, Carlini EA.
Psychoactive drug advertising: a comparison of technical information from three countries: Brazil, United States and United Kingdom.
Sao Paulo Med J 2005 Sep 1; 123:(5):209-14
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802005000500002&tlng=es&lng=en&nrm=iso
HSL5127
Clement OO, Guner OF.
Possibilities for transfer of relevant data without revealing structural information.
J Comput Aided Mol Des 2005 Sep-Oct 01; 19:(9-10):731-8
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3055&uid=16331404&db=PubMed&url=http://dx.doi.org/10.1007/s10822-005-9026-y
HSL5128
Tetko IV, Abagyan R, Oprea TI.
Surrogate data--a secure way to share corporate data.
J Comput Aided Mol Des 2005 Sep-Oct 01; 19:(9-10):749-64
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3055&uid=16267691&db=PubMed&url=http://dx.doi.org/10.1007/s10822-005-9013-3
HSL5129
Filimonov D, Poroikov V.
Why relevant chemical information cannot be exchanged without disclosing structures.
J Comput Aided Mol Des 2005 Sep-Oct 01; 19:(9-10):705-13
http://www.springerlink.com/(o4qobwznjmofl555qgrhoh55)/app/home/contribution.asp?referrer=parent&backto=issue,7,11;journal,4,131;linkingpublicationresults,1:102928,1
HSL5317
Bell DS, Friedman MA.
E-prescribing and the medicare modernization act of 2003. Paving the on-ramp to fully integrated health information technology?
Health Aff (Millwood) 2005 Sep-Oct 01; 24:(5):1159-69
http://content.healthaffairs.org/cgi/content/full/24/5/1159
HSL5379
Sittig DF, Krall M, Kaalaas-Sittig J, Ash JS.
Emotional aspects of computer-based provider order entry: a qualitative study.
J Am Med Inform Assoc 2005 Sep-Oct 01; 12:(5):561-7
http://www.jamia.org/cgi/content/full/12/5/561
HSL6001
A new era of hope for the world's most neglected diseases.
PLoS Med 2005 Sep 01; 2:(9):e323
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16138790
HSL6002
Moran M.
A breakthrough in R&D for neglected diseases: new ways to get the drugs we need.
PLoS Med 2005 Sep 01; 2:(9):e302
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16138789
HSL6005
Fischer A, Borensztein P, Roussel C.
The European rare diseases therapeutic initiative.
PLoS Med 2005 Sep 01; 2:(9):e243
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16104832
HSL6089
Adam M.
Integrating research and development: the emergence of rational drug design in the pharmaceutical industry.
Stud Hist Philos Biol Biomed Sci 2005 Sep 01; 36:(3):513-37
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VHP-4GY883C-6&_coverDate=09%2F30%2F2005&_alid=453175046&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6072&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=e0dfe9ab7ef476f05dab0b19835d8485
HSL6262
Nyigo VA, Malebo HM.
Drug discovery and developments in developing countries: bottlenecks and way forward.
Tanzan Health Res Bull 2005 Sep 01; 7:(3):154-8
HSL2117
Nielsen MW, Hansen EH, Rasmussen NK.
Use of natural medicines in the Danish population: a national cross-sectional survey.
Ann Pharmacother 2005 Sep; 39:(9):1534-8
http://www.theannals.com/cgi/content/full/39/9/1534
HSL2426
Miller DW, Miller CG.
On Evidence, Medical and Legal.
Journal of American Physicians and Surgeons 2005 Fall; 10:(3):70-75
http://www.jpands.org/vol10no3/miller.pdf
HSL3487
Mansfield PR.
Banning all drug promotion is the best option pending major reforms.
J Bioethical Inquiry 2005; 2:(2):16-22
HSL4593
Harris PR, Napper L.
Self-affirmation and the biased processing of threatening health-risk information.
Pers Soc Psychol Bull 2005 Sep; 31:(9):1250-63
http://psp.sagepub.com/cgi/reprint/31/9/1250
HSL4594
Gardikiotis A, Martin R, Hewstone M.
Group consensus in social influence: type of consensus information as a moderator of majority and minority influence.
Pers Soc Psychol Bull 2005 Sep; 31:(9):1163-74
http://psp.sagepub.com/cgi/reprint/31/9/1163
HSL4753
Connolly M.
Keeping the boat afloat: tips on fundraising strategies for your chapter.
Imprint 2005 Sep-Oct; 52:(4):50-1
HSL4755
Beersma B, De Dreu CK.
Conflict's consequences: effects of social motives on postnegotiation creative and convergent group functioning and performance.
J Pers Soc Psychol 2005 Sep; 89:(3):358-74
http://content.apa.org/journals/psp/89/3/358
HSL4772
Schwartz B.
Receiving gifts: a conflict of interest discussion.
J Can Dent Assoc 2005 Sep; 71:(8):561-2
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3166&uid=16202193&db=PubMed&url=http://www.cda-adc.ca/jcda/vol-71/issue-8/561.html
HSL4774
Huskamp HA, Shinogle JA.
Economic grand rounds: potential effects of the new medicare drug benefit on pricing for psychotropic medications.
Psychiatr Serv 2005 Sep; 56:(9):1056-8
http://ps.psychiatryonline.org/cgi/content/full/56/9/1056
HSL4783
Carroll J.
Plans struggle for control of specialty pharma costs.
Manag Care 2005 Sep; 14:(9):41-2
HSL4784
Lazarus A.
Individual wariness needed to spot biased drug research.
Manag Care 2005 Sep; 14:(9):8,
HSL4901
Cowin G.
Beware the language.
Aust Nurs J 2005 Sep; 13:(3):48
HSL4902
Richards D.
Real IR picture not in the advertising.
Aust Nurs J 2005 Sep; 13:(3):14
Page 101 of 144 pages ‹ First < 99 100 101 102 103 > Last ›
